πŸ‡ΊπŸ‡Έ FDA
Patent

US 8188221

Peptide homing to brain tumors

granted A61KA61K38/10A61P

Quick answer

US patent 8188221 (Peptide homing to brain tumors) held by The Regents of the University of California, UCSF expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California, UCSF
Grant date
Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/10, A61P, A61P35/00, A61P35/04